Anti-viral Platform

We are a fully integrated anti-viral platform focusing on developing and commercializing innovative, best-in-class drugs against HCV, HIV and HBV. Led by a management team with deep expertise and a proven track record, we have developed an integrated anti-viral platform covering the entire value chain from discovery and development to manufacturing and commercialization.


Ascletis provides both DAA + PR regimen and DAA all-oral regimen, offering a far higher cure rate of 97% to 99% and a shorter treatment period of 12 weeks.


With an unprecedented genetic barrier to resistance, ASC09 has the potential to be the best-in-class protease inhibitor to treat HIV -1 infections.


Our in-house HBV program at discovering stage is to develop novel therapies to achieve high functional cures for HBV.

Imagine what you could do at Ascletis

Our greatest assets are our employees. Ascletis is an equal opportunity employer and focused on providing a positive work environment where courageous innovation is encouraged and expected.

Our mission is to become a world-class biotechnology company addressing unmet medical needs in three therapeutic areas: anti-viral, cancer and fatty liver disease, for the patients in China and worldwide. Our highly talented team of researchers and professionals who passionately share in this common mission.

We offer competitive salaries and benefits that reward employees for their contribution to the company. If you’re interested in learning more about what we have to offer, please email your CV to We will look to match any current and upcoming openings to your area of expertise.